Mastocytosis Registry (of Zurich)

Launched by UNIVERSITY OF ZURICH · Jun 18, 2024

Keywords

ClinConnect Summary

The Mastocytosis Registry in Zurich is a clinical trial that aims to gather important information about patients with mastocytosis and high levels of tryptase (a protein that can be elevated in certain conditions). The researchers want to learn more about the demographics, treatment progress, and overall health of these patients. They will also collect biological samples, like blood and skin tissue, to use in future research. This helps scientists understand these conditions better and improve treatments.

To be eligible for the trial, participants need to be adults receiving treatment for mastocytosis or high tryptase levels at the University Hospital of Zurich. They must also provide informed consent, meaning they agree to participate after being fully informed about the study. If someone chooses not to participate, they will not be included in the study. Those who join can expect to contribute to valuable research that may help improve care for others with these conditions in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients with mastocytsis/hypertryptasemia which are treated at the university hospital of Zurich
• • available informed consent
• Exclusion Criteria:
• • denied consent